Evofem Biosciences (EVFM) Price & Analysis

Q: What was Evofem Biosciences’s price range in the past 12 months?

Evofem Biosciences lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.

Q: What is Evofem Biosciences’s market cap?

Evofem Biosciences’s market cap is $1.17M.

Q: When is Evofem Biosciences’s upcoming earnings report date?

Evofem Biosciences’s upcoming earnings report date is Nov 17, 2025 which is in 26 days.

Q: How were Evofem Biosciences’s earnings last quarter?

Evofem Biosciences released its earnings results on Aug 14, 2025. The company reported -$0.015 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.015.

Q: Is Evofem Biosciences overvalued?

According to Wall Street analysts Evofem Biosciences’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does Evofem Biosciences pay dividends?

Evofem Biosciences does not currently pay dividends.

Q: What is Evofem Biosciences’s EPS estimate?

Evofem Biosciences’s EPS estimate for its next earnings report is not yet available.

Q: How many shares outstanding does Evofem Biosciences have?

Evofem Biosciences has 118,656,360 shares outstanding.

Q: What happened to Evofem Biosciences’s price movement after its last earnings report?

Evofem Biosciences reported an EPS of -$0.015 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Q: Which hedge fund is a major shareholder of Evofem Biosciences?

Currently, no hedge funds are holding shares in EVFM

Compare

1,213 Followers

EVFM Stock Chart & Stats

$0.01

>-$0.01(-8.76%)

At close: Jan 08 4:00 PM EST

$0.01

>-$0.01(-8.76%)

Day’s Range― - ―

52-Week Range<$0.01 - $0.02

Previous CloseN/A

Volume1.62M

Average Volume (3M)777.57K

Market Cap

$1.17M

Enterprise Value$52.48M

Total Cash (Recent Filing)$221.00K

Total Debt (Recent Filing)$45.73M

Price to Earnings (P/E)―

Beta-0.05

Next Earnings

Nov 17, 2025

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.01

Shares Outstanding118,656,360

10 Day Avg. Volume707,701

30 Day Avg. Volume777,567

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap44.90

Enterprise Value/Revenue3.16

Enterprise Value/Gross Profit4.01

Enterprise Value/Ebitda-69.88

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusModerate Sell

Number of Analyst Covering0

Evofem Biosciences News

Evofem Biosciences Ends Merger with Aditxt, Refocuses Strategy

Evofem Biosciences ( ($EVFM) ) has provided an announcement. On October 20, 2025, Evofem Biosciences announced the termination...

1d ago

EVFM

Evofem Biosciences Amends Securities Purchase Agreement

An announcement from Evofem Biosciences ( ($EVFM) ) is now available. On October 13, 2025, Evofem Biosciences amended...

4d ago

EVFM

Evofem Biosciences Updates Merger Agreement with Aditxt

Evofem Biosciences ( ($EVFM) ) has issued an announcement. Evofem Biosciences, in collaboration with Aditxt, Inc., has entered...

2M ago

EVFM

Evofem says FDA Orange Book lists patent for Solosec treatment

Evofem (EVFM) Biosciences announced that a newly-issued U.S. patent which covers SOLOSEC 2 g oral granules and one...

2M ago

EVFM

Evofem Biosciences Reports Positive Q2 2025 Results

Evofem Biosciences, Inc. ( ($EVFM) ) has released its Q2 earnings. Here is a breakdown of the information...

2M ago

EVFM

Evofem Biosciences Enters Securities Purchase Agreement

Evofem Biosciences ( ($EVFM) ) has provided an announcement. On June 26, 2025, Evofem Biosciences, Inc. entered into...

4M ago

EVFM

Evofem announces Emirati health care filed application with UAE MOHAP

Evofem (EVFM) Biosciences announced that private Emirati health care company Pharma 1 Drug Store LLC has filed an...

4M ago

EVFM

Aditxt appoints Evofem CEO Saundra Pelletier to board

Aditxt (ADTX) announced the appointment of Saundra Pelletier, CEO of Evofem Biosciences (EVFM) to Aditxt’s board of directors....

4M ago

ADTX

EVFM

Evofem Biosciences Signs Agreement with Pharma 1

Evofem Biosciences ( ($EVFM) ) has provided an announcement. On May 19, 2025, Evofem Biosciences entered into a...

5M ago

EVFM

Evofem Biosciences Reports Q1 2025 Earnings

Evofem Biosciences, Inc. ( ($EVFM) ) has released its Q1 earnings. Here is a breakdown of the information...

5M ago

EVFM

Evofem Biosciences Amends Agreement with UAE Partner

Evofem Biosciences ( ($EVFM) ) has provided an announcement. On May 3, 2025, Evofem Biosciences, Inc. amended its...

6M ago

EVFM

Evofem announces license and supply agreement with Windtree Therapeutics

Evofem Biosciences (EVFM) announced that it has entered into a License and Supply Agreement with Windtree Therapeutics (WINT),...

7M ago

EVFM

WINT

Evofem Biosciences Reports Sales Growth and Strategic Advances

Evofem Biosciences, Inc. ( ($EVFM) ) has released its Q4 earnings. Here is a breakdown of the information...

7M ago

EVFM

Evofem Biosciences Reports Sales Growth and Strategic Moves

Evofem Biosciences ( ($EVFM) ) has issued an announcement. Evofem Biosciences reported a 6% increase in net sales...

7M ago

EVFM

EVFM FAQ

What was Evofem Biosciences’s price range in the past 12 months?

Evofem Biosciences lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.

What is Evofem Biosciences’s market cap?

Evofem Biosciences’s market cap is $1.17M.

When is Evofem Biosciences’s upcoming earnings report date?

Evofem Biosciences’s upcoming earnings report date is Nov 17, 2025 which is in 26 days.

How were Evofem Biosciences’s earnings last quarter?

Evofem Biosciences released its earnings results on Aug 14, 2025. The company reported -$0.015 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.015.

Is Evofem Biosciences overvalued?

According to Wall Street analysts Evofem Biosciences’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Evofem Biosciences pay dividends?

Evofem Biosciences does not currently pay dividends.

What is Evofem Biosciences’s EPS estimate?

Evofem Biosciences’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Evofem Biosciences have?

Evofem Biosciences has 118,656,360 shares outstanding.

What happened to Evofem Biosciences’s price movement after its last earnings report?

Evofem Biosciences reported an EPS of -$0.015 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Evofem Biosciences?

Currently, no hedge funds are holding shares in EVFM

Company Description

Evofem Biosciences

Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. Evofem Biosciences, Inc. is headquartered in San Diego, California.